| Parameter | Orforglipron (oral pill) | Retatrutide (injectable peptide) | | --- | --- | --- | | Molecular class | Non-peptide small molecule | Peptide (amino acid chain) | | Receptor profile | GLP-1 (single target) | GIP + GLP-1 + glucagon (triple) | | Administration | Oral, tablet | Subcutaneous injection | | Interval | Once daily | Once weekly | | Half-life | Short (daily dosing) | approx
Your physician will help determine which fits your health history and goals, and that evaluation is included with either program
The SURMOUNT-1 clinical trial demonstrated significant results across all dose groups
Starting with a Rybelsus oral tablet allows patients to benefit from GLP-1 therapy without the need for injections
Compounded semaglutide costs at PlexusDx are $189/mo month-to-month, or from $149/mo on the 6-month plan ($2,268/year ($189/mo)ly for the entry tier), leaving room in most FSA plans for other eligible medical expenses like copays, dental work, or vision care
Comparison with Placebo Groups The comparison between participants who received Ozempic and those who received a placebo in these trials highlighted the drugs superior effectiveness in weight loss